ロード中...
Single‐center study to determine the safety and efficacy of CT‐707 in Chinese patients with advanced anaplastic lymphoma kinase‐rearranged non‐small‐cell lung cancer
INTRODUCTION: It has been proven that ALK‐rearranged non‐small cell lung cancer (NSCLC) is sensitive to ALK inhibitors while the chemotherapy resistance is unavoidable. In this study, safety and antitumor activity of the novel ALK inhibitor (ALKi) CT‐707 were evaluated in Chinese patients with advan...
保存先:
| 出版年: | Thorac Cancer |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley & Sons Australia, Ltd
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7180692/ https://ncbi.nlm.nih.gov/pubmed/32181989 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13376 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|